Primary malignant bone tumours in Western Australia, 1972-1996
Primary malignant bone tumours in Western Australia, 1972-1996
复制标题
DOI：
10.1080/00313020500168737
复制
发表时间：
2005-08-01
期刊：
影响因子：
4.5
通讯作者：
McCaul, KA
中科院分区：
文献类型：
--
作者：
Blackwell, JB;Threlfall, TJ;McCaul, KA
目的：使用西澳骨肿瘤登记（BTR）数据库研究1972年至1996年西澳（WA）原发性恶性骨肿瘤的发病率，并将这些发病率与美利坚合众国（USA）的发病率进行比较。此外，对1980 - 1996年的BTR数据库和WA癌症登记处（WACR）数据库进行关联研究，以确定BTR记录是否可被视为基于人群的，并可有效用于确定WA的发病率。在回顾的每一年，计算骨肉瘤，软骨肉瘤，尤文氏肉瘤和所有骨肉瘤的总和。为了比较，发病率计算使用的数据从监测，流行病学和最终结果（SEER）计划注册在USA.Results：不包括骨髓瘤，有263例原发性恶性骨肿瘤。骨肉瘤94例，软骨肉瘤64例，尤文氏肉瘤49例，占原发性骨肉瘤的78.7%。WA的骨肉瘤的性别标准化发病率比美国低28%。对于软骨肉瘤和尤文氏肉瘤，没有显着差异，发现率在WA和美国。结论：BTR提供了一个宝贵的资源，为研究原发性骨肿瘤。这篇综述已经建立了可靠的发病率为个别类型的骨肉瘤。在这两个地区，原发性骨肉瘤的发病率略有上升趋势。
Aims: To study the incidence of primary malignant bone tumours in Western Australia (WA) from 1972 to 1996 using the database of the WA Bone Tumour Registry (BTR) and to compare these rates with those in the United States of America ( USA). In addition, to undertake a linkage study between the BTR database and that of the WA Cancer Registry (WACR) for the years 1980 - 1996 to determine if the BTR records could be regarded as population-based and valid for determining incidence rates in WA.Methods: For each year of the review, standardised incidence rates were calculated for osteosarcoma, chondrosarcoma, Ewing's sarcoma and for all bone sarcomas combined. For comparison, incidence rates were calculated using data obtained from the Surveillance, Epidemiology and End Results ( SEER) Program Registry in the USA.Results: Excluding myeloma, there were 263 cases of primary malignant bone tumours. Osteosarcoma ( 94 cases), chondrosarcoma ( 64 cases) and Ewing's sarcoma ( 49 cases), were the three most common and represented 78.7% of all primary bone sarcomas. Age-sex-standardised incidence rates for osteosarcoma in WA were 28% lower than in the USA. For chondrosarcoma and Ewing's sarcoma, no significant difference was found between rates in WA and the USA.Conclusions: The BTR provides a valuable resource for the study of primary bone tumours. This review has established reliable incidence rates for individual types of bone sarcoma. In both geographical sites there is a slight upward trend in the incidence of primary bone sarcoma.